Alnylam Pharmaceuticals Stock Technical Analysis
| ALNY Stock | USD 145.79 1.38 0.96% |
As of the 23rd of April, Alnylam Pharmaceuticals shows the Standard Deviation of 2.13, mean deviation of 1.42, and Risk Adjusted Performance of (0.10). Alnylam Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Alnylam Pharmaceuticals, which can be compared to its peers. Please confirm Alnylam Pharmaceuticals standard deviation and potential upside to decide if Alnylam Pharmaceuticals is priced correctly, providing market reflects its regular price of 145.79 per share. Given that Alnylam Pharmaceuticals has information ratio of (0.22), we suggest you to validate Alnylam Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
Alnylam Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Alnylam, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AlnylamAlnylam |
Alnylam Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 229.39 | Strong Buy | 30 | Odds |
Most Alnylam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alnylam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alnylam Pharmaceuticals, talking to its executives and customers, or listening to Alnylam conference calls.
Alnylam Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Alnylam Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alnylam Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Alnylam Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Alnylam Pharmaceuticals. You can use it to identify possible trend reversals for Alnylam Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alnylam Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Alnylam Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Alnylam Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.47 , which may suggest that Alnylam Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 8323.48, which is the sum of squared deviations for the predicted Alnylam Pharmaceuticals price change compared to its average price change.About Alnylam Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Alnylam Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Alnylam Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Alnylam Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Alnylam Pharmaceuticals. By analyzing Alnylam Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Alnylam Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Alnylam Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.91 | 1.72 | 5.59 | 5.87 | Days Of Inventory On Hand | 319.57 | 278.83 | 104.82 | 99.58 |
Alnylam Pharmaceuticals April 23, 2024 Technical Indicators
Most technical analysis of Alnylam help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alnylam from various momentum indicators to cycle indicators. When you analyze Alnylam charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.65) | |||
| Mean Deviation | 1.42 | |||
| Coefficient Of Variation | (560.79) | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.55 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.66) | |||
| Maximum Drawdown | 13.33 | |||
| Value At Risk | (3.20) | |||
| Potential Upside | 3.14 | |||
| Skewness | (1.20) | |||
| Kurtosis | 6.4 |
Alnylam Pharmaceuticals April 23, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Alnylam stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11,386 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 145.80 | ||
| Day Typical Price | 145.79 | ||
| Price Action Indicator | 0.68 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alnylam Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Alnylam Stock analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.52) | Revenue Per Share 14.637 | Quarterly Revenue Growth 0.312 | Return On Assets (0.05) | Return On Equity (15.01) |
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.